Concepedia

Thubeena Manickavasagar

TM

5

Publications

151

Citations

5

H-Index

2012

Active since

Affiliations

Institute of Cancer Research(Current)

Royal Marsden Hospital

Thubeena Manickavasagar is an author at Institute of Cancer Research specializing in molecular pharmacology, pharmacotherapy, and oncology.

Top concepts

Publications per year

2012–2024

5

Publications

5

Vitamin <scp>D</scp> deficiency in pregnancy – still a public health issue

Trixie McAree, Benjamin Jacobs, Thubeena Manickavasagar et al. · Maternal and Child Nutrition · 2012 · 78 citations · Full text

53P Assessing the reporting quality of early phase dose-finding trials

Christina Yap, Olga Solovyeva, Zhulin Yin et al. · Annals of Oncology · 2022 · 30 citations · Full text

Phase 1 trial of the adenosine A<sub>2A</sub> receptor antagonist inupadenant (EOS-850): Update on tolerability, and antitumor activity potentially associated with the expression of the A<sub>2A</sub> receptor within the tumor.

Laurence Buisseret, Sylvie Rottey, Johann S. de Bono et al. · Journal of Clinical Oncology · 2021 · 17 citations · Full text

, , +18

HER3 expression and MEK activation in non-small-cell lung carcinoma

Thubeena Manickavasagar, Wei Yuan, Suzanne Carreira et al. · Lung Cancer Management · 2021 · 16 citations · Full text

Predicting programmed death-ligand 1 (PD-L1) expression with fluorine-18 fluorodeoxyglucose ([18F]FDG) positron emission tomography/computed tomography (PET/CT) metabolic parameters in resectable non-small cell lung cancer

D.J. Hughes, Eleni Josephides, Robert O’Shea et al. · European Radiology · 2024 · 10 citations · Full text

Rows per page

1–5 of 5